TriaGen Wealth Management LLC Purchases New Stake in Doximity, Inc. $DOCS

Key Points

• TriaGen Wealth Management LLC made a new investment of approximately $450,000 in Doximity, acquiring 7,749 shares of the company in the first quarter.
• Insider transactions saw significant selling, with Director Timothy S. Cabral selling 10,000 shares for $600,000 and Director Regina M. Benjamin selling 5,000 shares for $315,000, resulting in decreases of 61.12% and 23.13% in their respective positions.
• Wall Street analysts have mixed outlooks for Doximity, with price targets ranging from $60.00 to $70.00 and an overall average rating of "Moderate Buy."

TriaGen Wealth Management LLC bought a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 7,749 shares of the company's stock, valued at approximately $450,000.

Other hedge funds also recently added to or reduced their stakes in the company. VSM Wealth Advisory LLC purchased a new position in Doximity in the first quarter valued at approximately $29,000. Allworth Financial LP increased its stake in Doximity by 104.0% in the first quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after purchasing an additional 287 shares during the last quarter. National Bank of Canada FI purchased a new position in Doximity in the first quarter valued at approximately $33,000. Spire Wealth Management increased its stake in Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares during the last quarter. Finally, Kapitalo Investimentos Ltda purchased a new position in Doximity in the fourth quarter valued at approximately $50,000. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

DOCS has been the subject of several research analyst reports. Bank of America increased their price objective on Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th. The Goldman Sachs Group set a $50.00 price objective on Doximity and gave the company a "neutral" rating in a report on Wednesday, May 21st. Canaccord Genuity Group increased their price target on Doximity from $50.00 to $59.00 and gave the stock a "hold" rating in a report on Friday, August 8th. KeyCorp increased their price target on Doximity from $65.00 to $70.00 and gave the stock an "overweight" rating in a report on Monday, July 14th. Finally, William Blair reaffirmed an "outperform" rating on shares of Doximity in a report on Friday, May 16th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $66.21.

Doximity Stock Up 5.0%

Shares of NASDAQ DOCS traded up $3.2130 during midday trading on Friday, hitting $67.3430. The stock had a trading volume of 798,477 shares, compared to its average volume of 2,317,541. The company has a market capitalization of $12.61 billion, a price-to-earnings ratio of 67.46, a PEG ratio of 4.10 and a beta of 1.36. Doximity, Inc. has a 1-year low of $35.32 and a 1-year high of $85.21. The company has a fifty day moving average price of $60.56 and a 200 day moving average price of $60.40.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The firm's quarterly revenue was up 15.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, research analysts forecast that Doximity, Inc. will post 0.99 EPS for the current year.

Insiders Place Their Bets

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the sale, the director directly owned 16,618 shares in the company, valued at $948,721.62. The trade was a 10.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $63.00, for a total value of $315,000.00. Following the sale, the director owned 16,618 shares in the company, valued at $1,046,934. This represents a 23.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 36,000 shares of company stock worth $2,140,940 in the last three months. 31.30% of the stock is owned by insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.